To view enhanced content for this article go to http://www.medengine.com/Redeem/05D4F0603D32D227.
Misuse of opioid analgesics, in combination with diversion, dependence, and fatal overdoses, presents a serious problem for public health, which affects many countries worldwide. Within this context, tampering with opioids has been associated with serious harm. The aim of the present study was to assess the tampering potential of codeine combination analgesics on the market (containing codeine/non-opioid analgesics) by the extraction of codeine.
Codeine was extracted from three combination formulations sold lawfully from licensed pharmacies without a medical prescription in Denmark and the UK. Extraction of codeine followed tampering procedures available on the Internet. The amounts of codeine and accompanying non-opioid analgesics in tampering products were analysed with liquid chromatography and tandem mass spectrometry (LC–MS/MS).
LC–MS/MS showed recoveries of the total amounts of codeine in tampering products of 81–84% from Product 1 (codeine/acetylsalicylic acid); 61–67% from Product 2 (codeine/ibuprofen); and 42–71% from Product 3 (codeine/paracetamol). Recoveries of non-opioid analgesics ranged between: 57–73% acetylsalicylic acid; 5.5–8.5% ibuprofen, and 5.0–9.2% paracetamol.
With the tampering procedures used, high amounts of codeine were separated from the accompanying analgesics in some, but not in all of the codeine containing formulations. Evidence-based medicine regulation, treatment for opioid dependence, and information to minimise risks to the public are essential components of an effective public health strategy to address the harms of tampering and misuse.
Marie Pedersen and Jensine Heiberg Foundation.
British Medical Association. Prescribed drugs associated with dependence and withdrawal—building a consensus for action. London: BMA; 2015.
Advisory Council on the Misuse of Drugs. ACMD consideration of tramadol. London: ACMD; 2013.
Medicines and Healthcare Products Regulatory Agency. MHRA public assessment report. Codeine and dihydrocodeine-containing medicines: minimising the risk of addiction. London: MHRA; 2009.
Dale-Perera A, Goulão J, Stöver H. Quality of care provided to patients receiving opioid maintenance treatment in Europe: results from the EQUATOR analysis. Heroin Addict Relat Clin Probl. 2012;14:23–38.
Office for National Statistics. Statistical Bulletin. Deaths related to drug poisoning in England and Wales, 2014 registrations. London: Office for National Statistics; 2015.
European Monitoring Centre for Drugs and Drug Addiction. European drug report. Trends and developments 2015. Lisbon: EMCDDA; 2015.
Jonsson B, Backman E, Salmonson H, Höjer J. Injection of crushed tablets—a prospective observational study. Clin Toxicol. 2014;52:982–3. CrossRef
Dale E, Ashby F, Seelam K. Report of a patient chewing fentanyl patches who was titrated onto methadone. BMJ Case Rep. 2009. doi: 10.1136/bcr.01.2009.1454.
Frei MY, Nielsen S, Dobbin MDH, Tobin CL. Serious morbidity associated with misuse of over-the-counter codeine-ibuprofen analgesics: a series of 27 cases. Med J Aust. 2010;193:294–6. PubMed
Locher C, Lambare B, Fischer D, Labayle D. Acute pancreatitis induced by codeine-acetaminophen association: report of two cases. Gastroenterol Clin Biol. 2003;27:124–5. PubMed
Alaygut D, Torun-Bayram M, Ünlü M, Soylu A, Türkmen M, Kavukçu S. Acute tubulointerstitial nephritis-uveitis (TINU) syndrome developed secondary to paracetamol and codeine phosphate use: two case reports. Turk J Pediatr. 2014;56:92–6. PubMed
Dutch MJ. Nurofen Plus misuse: an emerging cause of perforated gastric ulcer. Med J Aust. 2008;188:56–7. PubMed
Torper J, Steine S. Patients’ experience with withdrawal of addictive drugs. Tidsskr Nor Laegeforen. 2004;124:2342–4. PubMed
Donuk T, Altıntoprak AE, Tekin H. Possible causal link between idiopathic intracranial hypertension and the misuse of codeine-based products. J Child Adolesc Psychopharmacol. 2015. [Epub ahead of print 28 July 2015].
Chan J. Cold water extraction (CWE). https://www.youtube.com/watch?v=1_ThfoEL5f0. Accessed 26th April 2016.
Haynes A, Kleinschmidt K, Forrester MB, Young A. Trends in analgesic exposures reported to Texas Poison Centers following increased regulation of hydrocodone. Clin Toxicol. 2016;54:434–40.
Fingleton NA, Watson MC, Duncan EM, Matheson C. Non-prescription medicine misuse, abuse and dependence: a cross-sectional survey of the UK general population. J Public Health. 2016. [Epub ahead of print 2 February 2016].
Kean J. Illicit and over-the-counter codeine dependence after acute back pain- successful treatment and ongoing recovery after buprenorphine/naloxone taper. Heroin Addict Relat Clin Probl. 2016;18:21–4.
Hard B. Management of opioid painkiller dependence in primary care: ongoing recovery with buprenorphine/naloxone. BMJ Case Rep. 2014. doi: 10.1136/bcr-2014-207308.
International Narcotics Control Board. Estimated world requirements for 2015: statistics for 2013. New York: United Nations; 2014.
Cooper R. Surveillance and uncertainty: community pharmacy responses to over the counter medicine abuse. Health Soc Care Comm. 2013;21:254–62. CrossRef
Ionium. Kodeinekstraktion fra kodimagnyler for dummies! [Codeine extraction from kodimagnyler for dummies!]. https://psychedelia.dk/forum/viewtopic.php?f=80&t=12994&sid=d5600ec75c3cf16a37f9ba0ef142f086. Accessed 26 April 2016.
Psychonautwiki. Extraction of opioids from painkiller products. https://psychonautwiki.org/wiki/Extraction_of_opioids_from_painkiller_products. Accessed 26 April 2016.
Kramorph. Improved CWE codeine extraction. http://forum.opiophile.org/showthread.php?457-Improved-CWE-codeine-extraction. Accessed 4 Jan 2015.
Harris SC, Perrino PJ, Smith I, Shram MJ, Colucci SV, Bartlett C, et al. Abuse potential, pharmacokinetics, pharmacodynamics, and safety of intranasally administered crushed oxycodone HCl abuse-deterrent controlled-release tablets in recreational opioid users. J Clin Pharmacol. 2013;54:468–77. CrossRefPubMed
Kimergård A, Breindahl T, Hindersson P, Deluca P. Tampering of opioid analgesics: a serious challenge for public health? Addiction. 2016 (in press).
BNF. Ibuprofen. https://www.medicinescomplete.com/mc/bnf/current/PHP6461-ibuprofen.htm?q=ibuprofen&t=search&ss=text&tot=182&p=1#_hit. Accessed 26 April 2016.
BNF. Codeine phosphate. https://www.medicinescomplete.com/mc/bnf/current/PHP460-codeine-phosphate.htm?q=codeine&t=search&ss=text&tot=199&p=3#_hit. Accessed 26 April 2016.
BNF. Paracetamol (“acetaminophen”). https://www.medicinescomplete.com/mc/bnf/current/PHP2632-paracetamol.htm?q=paracetamol&t=search&ss=text&tot=354&p=1#_hit. Accessed 26 April 2016.
Aspirin (acetylsalicylic acid). https://www.medicinescomplete.com/mc/bnf/current/PHP2596-aspirin.htm?q=acetylsalicylic%20acid&t=search&ss=text&tot=152&p=1#_hit. Accessed 26 April 2016.
Schou M, Svennum V. Acute salicylate poisoning may cause non-cardiogenic pulmonary edema. Lakartidningen. 2012;109:700–1. PubMed
Løgstrup BB, Øgaard S. Hypokalaemia as a result of abuse of Kodimagnyl. Ugeskr Laeger. 2007;169:520. PubMed
Christiansen MH, Thomsen AH, Andersen LV. Chronic salicylate poisoning is a challenging diagnosis. Ugeskr Laeger. 2015;177:1151–2. PubMed
Centers for Disease Control and Prevention. Today’s heroin epidemic. Atlanta: Centers for Disease Control and Prevention; 2015.
Warner M, Hedegaard H, Chen L-H. Trends in drug-poisoning deaths involving opioid analgesics and heroin: United States, 1999–2012. Hyattsville: CDC/National Center for Health Statistics; 2014.
Conroy S, Hill D. Failure to identify or effectively manage prescription opioid dependence acted as a gateway to heroin use—buprenorphine/naloxone treatment and recovery in a surgical patient. BMJ Case Rep. 2014. doi: 10.1136/bcr-2014-207458.
Medicines and Healthcare Products Regulatory Agency. Welcome to the reporting site for the Yellow Card Scheme. https://yellowcard.mhra.gov.uk. Accessed 26 April 2016.
Danish Medicines Agency. Meld en bivirkning ved medicin til mennesker—for sundhedsprofessionelle (e-blanket) [Report a side effect to a medicine (human)—for health professionals (e-form). http://laegemiddelstyrelsen.dk/da/bivirkninger/bivirkninger-ved-medicin/meld-en-bivirkning/mennesker/meld-en-bivirkning-ved-medicin-til-mennesker-for-sundhedsprofessionelle-e-blanket. Accessed 26 April 2016.
- How Resistant to Tampering are Codeine Containing Analgesics on the Market? Assessing the Potential for Opioid Extraction
- Springer Healthcare
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
e.Med Kampagnen-Visual, Mail Icon II